B cell-deficient (μMT) mice have alterations in the cytokine microenvironment of the gut-associated lymphoid tissue (GALT) and a defect in the low dose mechanism of oral tolerance

Journal of Immunology

Volumn 166, Issue 7, 2001, Pages 4456-4464

  Gonnella, P A ^a   Waldner, H P ^a   Weiner, H L ^a  

^a HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL PROTECTION; CELL STIMULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; ENCEPHALOMYELITIS; IMMUNOLOGICAL TOLERANCE; INTESTINE LYMPHATIC TISSUE; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL;

EID: 0035313114     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.7.4456     Document Type: Article

References (33)

1. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens
2. B cells turn off virgin but not memory T-cells
3. B cell presentation of a tolerogenic signal
4. + T-cell activation and tolerance induction in B cell knockout mice
5. Analysis of low zone tolerance induction in normal and B cell-deficient mice
6. B cells are not essential for peripheral T-cell tolerance
7. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion
8. T cell tolerance in transgenic mice expressing major histocompatibility class 1 molecules in defined tissues
9. Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self-antigen
10. Levels of peripheral T cell tolerance induced by different doses of tolerogen
11. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization
12. Oral tolerance: Mechanisms and therapeutic applications
13. In situ immune response in gut associated lymphoid tissue (GALT) following oral antigen in TcR transgenic mice
14. Oral tolerance in experimental autoimmune uveoretinitis: Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols
15. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage
16. Orally induced immune responsiveness is abrogated by IFN-γ treatment
17. Immunosuppression caused by antigen feeding. II. Suppressor T-cells mask Peyer's patches B cell priming to orally administered antigen
18. Immunologic suppression after oral administration of antigen. III. Activation of suppressor-inducer cells in the Peyer's patches
19. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy
20. Collection of mouse thoracic duct lymphocytes
21. + cells mediate active suppression
22. Quantitative evaluation of the gastrointestinal absorption of protein into the blood and lymph circulation
23. B-cell depletion fails to abrogate the induction of oral tolerance of specific Th1 immune responses in mice
24. Organogenic role of B lymphocytes in mucosal immunity
25. Peripheral deletion of antigen-reactive T-cells in oral tolerance
26. Priming of systemic and local delayed-type hypersensitivity responses by feeding low doses of ovalbumin to mice
27. The influence of oral immunization on local and systemic immune responses to heterologous antigens
28. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines
29. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease
30. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: Evidence that the protective mechanism depends on changes in the cytokine response and migratory, properties of the autoantigen-specific T-cells
31. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions
32. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
33. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice